At 6.8% CAGR, Global Transplant Diagnostics Market Size Worth USD 10,139.38 million by 2029
Transplant diagnostics are the immunogenetics and histocompatibility of organ and hematopoietic stem cell transplantations. These diagnostics help healthcare professionals determine compatibility between potential recipients and organ donors. These are used in various disciplines, such as immunogenetics, pathology and infectious diseases, among others.

Data Bridge Market Research analyzes that the global transplant diagnostics market is expected to reach a value of USD 10,139.38 million by 2029, at a CAGR of 6.8% during the forecast period.

A market research conducted in the widespread Global Transplant Diagnostics Market business report aids in improving and modifying the products so that future products present more satisfaction to the valuable customers. By keeping in mind the end user’s point of view, a team of researchers, forecasters, analysts and industry experts work in-depth to formulate this market research report. The company profiles of all the top players and brands that are leading the Global Transplant Diagnostics Market with moves like product launches, joint ventures, mergers, and acquisitions which in turn is affecting the sales, import, export, revenue and CAGR values are revealed in this market research document.

Global Transplant Diagnostics Market analysis report identifies and analyses the up-and-coming trends along with major drivers, restraints, challenges and opportunities in the market for Healthcare industry. It is the most appropriate, realistic and admirable market research report delivered with a supreme devotion and comprehension of business needs. This market document deals with an array of important market related aspects which can be listed as follows; market size estimations, company and market best practices, entry level strategies, market dynamics, positioning, segmentations, competitive landscaping and benchmarking, opportunity analysis, economic forecasting, industry-specific technology solutions, roadmap analysis, and in-depth benchmarking of vendor offerings.

Global Transplant Diagnostics Market Scope and Market Size

The global transplant diagnostics market is segmented into product type, technology, transplant type, application, end user and distribution channel. The growth among segments helps you analyze niche pockets of growth and strategies to approach the market and determine your core application areas and the difference in your target markets.

Product Type

·        Transplant Diagnostic Instrument

·        Transplant Diagnostic Software

·        Transplant Diagnostic Reagent

On the basis of product type, the global transplant diagnostics market is segmented into transplant diagnostic instrument, transplant diagnostic software and transplant diagnostic reagent.


·        PCR-Based Molecular Assays

·        Sequencing-Based Molecular Assays

On the basis of technology, the global transplant diagnostics market is segmented into PCR-based molecular assays and sequencing-based molecular assays.

·        Transplant Type

·        Solid Organ Transplantation

·        Stem Cell Transplantation

·        Soft Tissue Transplantation

·        Bone Marrow Transplantation

·        Other Transplants

On the basis of transplant type, the global transplant diagnostics market is segmented into solid organ transplantation, stem cell transplantation, soft tissue transplantation, bone marrow transplantation and other transplants.


·        Diagnostic Applications

·        Research Applications

On the basis of application, the global transplant diagnostics market is segmented into diagnostic applications and research applications.

End User

·        Hospitals And Transplant Centers

·        Commercial Service Providers

·        Research Laboratories And Academic Institutes

·        Others

On the basis of end user, the global transplant diagnostics market is segmented into research laboratories and academic institutes, hospitals and transplant centers, commercial service providers and others.

Distribution Channel

·        Direct Tender

·        Retail Sales

·        Others

Get the Free sample copy of the report here:

Some of the key questions answered in this report:

·        How has the Global Transplant Diagnostics Market performed so far and how will it perform in the coming years?

·        What has been the impact of COVID-19 on the Global Transplant Diagnostics Market?

·        What are the key regional markets?

·        What is the breakup of the market based on the procedure?

·        What is the breakup of the market based on the injury location?

·        What is the breakup of the market based on the end user?

·        What are the various stages in the value chain of the industry?

·        What are the key driving factors and challenges in the industry?

·        What is the structure of the Global Transplant Diagnostics Market and who are the key players?

·        What is the degree of competition in the industry?

Market Analysis and Insights: Global Transplant Diagnostics Market

·        Transplant diagnosis is a diagnostic procedure usually divided into pre-transplant and post-transplant procedures. It helps to analyze the health status of the patient. If this is avoided, the immunocompromised person is at risk of developing HAI or worse, which can lead to death. The procedure is a harmonious collaboration between healthcare professionals and laboratory experts, ensuring better patient outcomes. In addition, close matching of donor and recipient HLA markers is important. This increases the likelihood of graft survival and minimizes serious complications of immunological transplantation.

·        The increased prevalence of chronic illnesses among the worldwide population is likely to drive market expansion throughout the forecast years. Furthermore, the increasing use of stem cell therapy and personalized medications is gaining popularity. The use of new diagnostic techniques has improved the medical outcomes of organ transplants. The rate of organ rejection can be reduced by matching the compatibility of the donor and recipient before transplantation.

·        However, the high cost of procedures associated with PCR and NGS diagnostic instruments is one of the most significant. As a result, market growth may be hampered in the long run. The cost of medical equipment is one element that may challenge critical transplant diagnosis device vendors.

·        Product type accounts for the largest segment in the market due to the rapid demand for transplant diagnostics globally. This market report also covers pricing analysis, patent analysis and technological advancements in depth.

·        Transplant diagnostics are the immunogenetics and histocompatibility of organ and hematopoietic stem cell transplantations. These diagnostics help healthcare professionals determine compatibility between potential recipients and organ donors. These are used in various disciplines, such as immunogenetics, pathology and infectious diseases, among others. Transplant diagnostics are used to determine whether the donor and the recipient of the organ are compatible before or after the transplant.

·        With the introduction of transplant diagnostics, the prevalence of diseases that can cause organ failure, including both pre-and post-transplant screening, is expected to explode. The market has attracted the interest of healthcare professionals due to the many advantages these tests offer to verify suitability for a transplant procedure. Organ transplantation is one of the most popular treatment options for many end-stage renal disease patients on continuous dialysis.

·        In addition, it is possible to investigate organ transplantation for cases involving the heart, liver, or bone marrow. Although in many cases, there is a strong association between renal failure and liver transplantation, including end-stage renal disease. New transcriptomic, proteomic and genomic indicators in molecular diagnostics can help to better tailor transplant therapy and early detection of rejection events. Also, strategic initiatives by market players, technological progressions in transplant diagnostics, high sterility assurance and increasing investment in healthcare infrastructure increase the demand for transplant diagnostics.

Key Pointers Covered in Global Transplant Diagnostics Market Industry Trends and Forecast to 2029

·        Market Size

·        Market New Sales Volumes

·        Market Replacement Sales Volumes

·        Market By Brands

·        Market Procedure Volumes

·        Market Product Price Analysis

·        Market Regulatory Framework and Changes

·        Market Shares in Different Regions

·        Recent Developments for Market Competitors

·        Market Upcoming Applications

·        Market Innovators Study

Global Transplant Diagnostics Market Country Level Analysis

Some countries covered in the global transplant diagnostics market are the U.S., Canada, Mexico, Germany, France, U.K., Italy, Spain, Russia, Turkey, Belgium, Netherlands, Switzerland and the rest of Europe, China, Japan, India, South Korea, Singapore, Thailand, Malaysia, Australia, Philippines, Indonesia and the rest of Asia-Pacific, South Africa, Saudi Arabia, U.A.E, Egypt, Israel and the rest of the Middle East and Africa.

Global Transplant Diagnostics Market Share Analysis

The global transplant diagnostics market competitive landscape provides details by the competitor. Details included are company overview, company financials, revenue generated, market potential, investment in R&D, new market initiatives, production sites and facilities, company strengths and weaknesses, product launch, product trials pipelines, product approvals, patents, product width and breath, application dominance, technology lifeline curve. The above data points provided are only related to the company's focus on the global transplant diagnostics market.

Key player Global Transplant Diagnostics Market

Some of the major players operating in the global transplant diagnostics market are Hologic, Inc., Biofortuna Limited, Takara Bio Inc., Abbott, Diagnóstica Longwood SL, Adaptive Biotechnologies, NanoString, Arquer Diagnostics Ltd, altona Diagnostics GmbH, ELITechGroup, DiaSorin S.p.A., Horiba Ltd, EUROFINS VIRACOR, CareDx Inc., Laboratory Corporation of America Holdings., Randox Laboratories Ltd., Thermo Fisher Scientific Inc., Preservation Solutions, Inc., TransMedics, Transonic, Stryker, Bio-Rad Laboratories, Inc., Zimmer Biomet, QIAGEN, F. Hoffmann-La Roche Ltd, BIOMÉRIEUX, Illumina, Inc., Luminex Corporation (A subsidiary of DiaSorin Company), CLONIT srl, PathoNostics, Biotype GmbH, BAG Diagnostics GmbH, IMMUCOR, among others.

 Get Full Access of Report@


·        Chapter One: Introduction

·        Chapter Two: Market Segmentation

·        Chapter Three: Market Overview

·        Chapter Four: Executive Summary

·        Chapter Five: Premium Insights

·        Chapter Six: Global Transplant Diagnostics Market Share by Product & Procedure type

Get TOC Details:

Top Trending Reports:










About Us:

Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market


Data Bridge Market Research

Tel: +1-888-387-2818